FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Julie Vose

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Julie M Vose; Richard Ambinder; Ernesto Ayala; Linda J Burns; Shelly Carter; Timothy Fenske; Richard Fisher; Mary Horowitz; Shin Mineshi; Craig H Moskowitz; Oliver W Press; Edward A Stadtmauer; Marcie Tomblyn
Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial.
Julie M Vose; Edmund K Waller; Bruce D Cheson; Jonathan W Friedberg; Holger Fritsch; Vasthala Juvvigunta; Gerd Munzert; Claude Petit; Anas Younes
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.
Massimo Federico; Nancy L Harris; Elaine S Jaffe; stefano luminari; Nicholas Mounier; Bharat N Nathwani; Stefano A Pileri; Thomas Rudiger; Kerry J Savage; James O Armitage; Monica Bellei; Bertrand Coiffier; Dennis D Weisenburger; Julie M Vose
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Julie Vose (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Julie M Vose; Richard Ambinder; Ernesto Ayala; Linda J Burns; Shelly Carter; Timothy Fenske; Richard Fisher; Mary Horowitz; Shin Mineshi; Craig H Moskowitz; Oliver W Press; Edward A Stadtmauer; Marcie Tomblyn
Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(13):1662-8.
2013: Julie M Vose; Edmund K Waller; Bruce D Cheson; Jonathan W Friedberg; Holger Fritsch; Vasthala Juvvigunta; Gerd Munzert; Claude Petit; Anas Younes
The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.
Leukemia & lymphoma 2013;54(4):708-13.
2013: Massimo Federico; Nancy L Harris; Elaine S Jaffe; stefano luminari; Nicholas Mounier; Bharat N Nathwani; Stefano A Pileri; Thomas Rudiger; Kerry J Savage; James O Armitage; Monica Bellei; Bertrand Coiffier; Dennis D Weisenburger; Julie M Vose
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):240-6.
2013: Julie M Vose; Dennis D Weisenburger; Philip J Bierman; R Gregory Bociek; Wing C Chan; Charles A Enke; Jordan Hankins; Fausto R Loberiza; James O Armitage
Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):123-8.
2012: Ganapati V Hegde; Philip J Bierman; Amit K Mittal; Corey M Munger; Tara M Nordgren; J Graham Sharp; Julie M Vose; Dennis D Weisenburger; Shantaram S Joshi
Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling.
International journal of cancer. Journal international du cancer 2012;131(12):2951-60.
2012: Ulrike Bacher; Michael R Bishop; Christopher N Bredeson; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Cesar O Freytes; Robert Peter Gale; John Gibson; Parameswaran Hari; David J Inwards; Luis M Isola; Evgeny Klyuchnikov; Ginna G Laport; Hillard M Lazarus; Jennifer Le-Rademacher; Richard T Maziarz; Harry C Schouten; Shimon Slavin; Sonali M Smith; Julie M Vose; Edmund K Waller; Peter H Wiernik; Philippe Armand
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Blood 2012;120(20):4256-62.
2012: Corey M Munger; Julie M Vose; Dennis D Weisenburger; Ganapati V Hegde; Shantaram S Joshi
Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.
Cancer immunology, immunotherapy : CII 2012;61(10):1819-32.
2012: Anamarija M Perry; Lisa M Rimsza; Andreas Rosenwald; Laurie H Sehn; Lynette M Smith; Louis M Staudt; Raymond Tubbs; Julie M Vose; Rita M Braziel; Elias Campo; Teresa M Cardesa-Salzmann; Wing C Chan; Luis Colomo; Joseph Michael Connors; James R Cook; Jan Delabie; Kai Fu; Randy D Gascoyne; Timothy C Greiner; Elaine S Jaffe; Armando López-Guillermo; Paul N Meyer; German Ott; Dennis D Weisenburger
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
Blood 2012;120(11):2290-6.
2012: Julie M Vose
Autotransplantation for mantle cell lymphoma.
Cancer journal (Sudbury, Mass.) 2012;18(5):427-31.
2012: Deborah L Darrington; Julie M Vose
Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.
Current hematologic malignancy reports 2012;7(3):200-7.
2012: Keni Gu; Zhongfen Liu; Lynette M Smith; Dennis D Weisenburger; Patricia Aoun; James O Armitage; Martin Bast; Philip J Bierman; R Gregory Bociek; Wing C Chan; Kai Fu; Timothy C Greiner; Julie M Vose
Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.
Hematological oncology 2012;30(3):143-9.
2012: Zdravko Mitrovic; Emili Monserrat; Anamarija M Perry; Sandeep K Rajan; Kerry J Savage; Junji Suzumiya; Kensei Tobinai; Julie M Vose; James O Armitage; Wing Y Au; Bertrand Coiffier; Harald Holte; Elaine S Jaffe; Dennis D Weisenburger
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.
American journal of hematology 2012;87(8):790-4.
2012: Cesar O Freytes; Robert Peter Gale; John Gibson; Thomas G Gross; gregory alan hale; Linda J Burns; Jeanette Carreras; David J Inwards; Luis Isola; Thomas R Klumpp; Hillard M Lazarus; David I Marks; Rodrigo Martino; Alan M Miller; Santiago Pavlovsky; Miguel-Angel Perales; Philip Rowlings; Harry C Schouten; Matthew Seftel; Simon Slavin; Sonali M Smith; Koen van Besien; Julie M Vose; Mei-Jie Zhang; Parameswaran N Hari
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(8):1255-64.
2012: Wei Li; Julie M Vose; Philip J Bierman; R Gregory Bociek; Karen Holdeman; Javier A Laurini; James O Armitage
Sarcoidosis mimicking recurrent lymphoma.
American journal of hematology 2012;87(7):711-2.
2012: Bruce D Cheson; Anne T Keating; Andres Lopez-Hernandez; Amanda L Seiz; Setareh Shamsili; Julie M Vose; Nancy L Bartlett; Kyriakos P Papadopoulos
A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma.
Cancer 2012;118(12):3128-34.
2012: Julie M Vose
Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
American journal of hematology 2012;87(6):604-9.
2012: Javeed Iqbal; Elaine S Jaffe; Cynthia M Lachel; Cuiling Liu; Yanyan Liu; Zhongfeng Liu; Timothy W McKeithan; German Ott; Lisa M Rimsza; Andreas Rosenwald; Yulei Shen; Louis M Staudt; Raymond R Tubbs; Julie M Vose; Dennis D Weisenburger; James O Armitage; Sharathkumar Bhagavathi; Rita M Braziel; Elias Campo; James R Cook; Karen Deffenbacher; Jan Delabie; Kai Fu; Randy D Gascoyne; Timothy C Greiner; Wing C Chan
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.
Blood 2012;119(21):4939-48.
2012: Zdravko Mitrovic; Julie M Vose; Martin Bast; Philip J Bierman; R Gregory Bociek; Wing C Chan; James O Armitage
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
British journal of haematology 2012;157(3):401-3.
2011: Javeed Iqbal; Elaine Jaffe; Nathalie A Johnson; Paul N Meyer; German Ott; Lisa M Rimsza; Andreas Rosenwald; Lynette M Smith; Louis M Staudt; Raymond R Tubbs; Julie M Vose; Dennis D Weisenburger; James O Armitage; Rita M Braziel; Elias Campo; Joseph Michael Connors; James R Cook; Jan Delabie; Randy D Gascoyne; Timothy C Greiner; Wing C Chan
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(24):7785-95.
2011: Julie M Vose
Relapsed diffuse large B-cell lymphoma: clinical utility of cell of origin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(31):4065-6.
2011: Myron S Czuczman; Annetti Ervin-Haynes; Ju Li; Dennis Pietronigro; Jonathan Polikoff; Julie M Vose; Thomas E Witzig; Pier L Zinzani; Rena Buckstein; Craig B Reeder
The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin.
British journal of haematology 2011;154(4):477-81.
2011: Dennis D Weisenburger; Kerry J Savage; Nancy Lee Harris; Randy D Gascoyne; Elaine S Jaffe; KA MacLennan; Thomas Rüdiger; Stefano Pileri; Shigeo Nakamura; Bharat N Nathwani; Elias Campo; Francoise Berger; Bertrand Coiffier; Won Seog Kim; Harald Holte; Massimo Federico; Wing Y Au; Kensei Tobinai; James O Armitage; Julie M Vose
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.
Blood 2011;117(12):3402-8.
2011: Jonathan W Friedberg; Julie M Vose; Jennifer L Kelly; Faith Young; Steven H Bernstein; Derick Peterson; Lynn Rich; Susan Blumel; Nicole K Proia; Jane Liesveld; Richard I Fisher; James O Armitage; Steven Grant; John P Leonard
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.
Blood 2011;117(10):2807-12.
2011: Jia Ruan; Peter Martin; Richard R Furman; Shing M Lee; Ken Cheung; Julie M Vose; Ann S LaCasce; Julia Morrison; Rebecca L Elstrom; Scott Ely; Amy Chadburn; Ethel Cesarman; Morton Coleman; John P Leonard
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):690-7.
2011: Javeed Iqbal; Dennis D Weisenburger; A Chowdhury; M Y Tsai; G Srivastava; Timothy C Greiner; C Kucuk; K Deffenbacher; Julie M Vose; Lynette Smith; Wing Y Au; S Nakamura; M Seto; Jan Delabie; F Berger; F Loong; Young Hyeh Ko; I Sng; X Liu; T P Loughran; J Armitage; Wing C Chan
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
Leukemia 2011;25(2):348-58.
2011: Paul N Meyer; Kai Fu; Timothy C Greiner; Lynette M Smith; Jan Delabie; Randy D Gascoyne; German Ott; Andreas Rosenwald; Rita M Braziel; Elias Campo; Julie M Vose; Georg Lenz; Louis M Staudt; Wing C Chan; Dennis D Weisenburger
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(2):200-7.
2010: Anas Younes; Julie M Vose; Andrew D Zelenetz; M R Smith; H A Burris; S M Ansell; J Klein; W Halpern; R Miceli; E Kumm; N L Fox; Myron S Czuczman
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma.
British journal of cancer 2010;103(12):1783-7.
2010: Richard R Furman; Peter Martin; Jia Ruan; Ying-Kuen K Cheung; Julie M Vose; Ann S LaCasce; Rebecca L Elstrom; Morton Coleman; John P Leonard
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
Cancer 2010;116(23):5432-9.
2010: Julie M Vose; Dennis D Weisenburger; Fausto R Loberiza; Alejandro Arevalo; Martin Bast; J Armitage; Philip J Bierman; Robert G Bociek; James O Armitage
Late relapse in patients with diffuse large B-cell lymphoma.
British journal of haematology 2010;151(4):354-8.
2010: Anthony J Cannon; Deborah L Darrington; Helen E McIlvain; Linda K Bauer; Julie M Vose; James O Armitage; Fausto R Loberiza
Association of number of follow-up providers with outcomes in survivors of hematologic malignancies.
Leukemia & lymphoma 2010;51(10):1862-9.
2010: Julie M Vose
Understanding evaluation and management of primary cutaneous and systemic ALCL.
Oncology (Williston Park, N.Y.) 2010;24(7):594.
2010: Julie M Vose
Status of ongoing collaborative efforts.
Seminars in hematology 2010;47 Suppl 1():S18-20.
2010: Jonathan W Friedberg; Jeff Sharman; John Sweetenham; Patrick B Johnston; Julie M Vose; Ann S LaCasce; Julia Schaefer-Cutillo; Sven De Vos; Rajni Sinha; John P Leonard; Larry D Cripe; Stephanie A Gregory; Michael P Sterba; Ann M Lowe; Ronald Levy; Margaret A Shipp
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Blood 2010;115(13):2578-85.
2010: Edward A Faber; Julie M Vose
The role of hematopoietic stem cell transplant in follicular lymphoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(3):337-44; quiz 345.
2010: Andrew D Zelenetz; Jeremy S Abramson; Ranjana H Advani; C Babis Andreadis; John C Byrd; Myron S Czuczman; Luis Fayad; Andres Forero; Martha J Glenn; Jon P Gockerman; Leo I Gordon; Nancy Lee Harris; Richard T Hoppe; Steven Horwitz; Mark S Kaminski; Youn H Kim; Ann S LaCasce; Tariq I Mughal; Auyporn Nademanee; Pierluigi Porcu; Oliver Press; Leonard Prosnitz; Nashitha Reddy; Mitchell R Smith; Lubomir Sokol; Lode Swinnen; Julie M Vose; William G Wierda; Joachim Yahalom; Furhan Yunus
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(3):288-334.
2010: Javeed Iqbal; Dennis D Weisenburger; Timothy C Greiner; Julie M Vose; Timothy W McKeithan; Can Kucuk; Huimin Geng; Karen Deffenbacher; Lynette Smith; Karen Dybkaer; Shigeo Nakamura; Masao Seto; Jan Delabie; Francoise Berger; Florence Loong; Wing Y Au; Young Hyeh Ko; Ivy Sng; James Olen Armitage; Wing C Chan
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.
Blood 2010;115(5):1026-36.
2010: Hillard M Lazarus; Mei-Jie Zhang; Jeanette Carreras; Brandon Hayes-Lattin; Asli Selmin Ataergin; Jacob D Bitran; Brian J Bolwell; Cesar O Freytes; Robert Peter Gale; Steven C Goldstein; gregory alan hale; David J Inwards; Thomas R Klumpp; David I Marks; Richard T Maziarz; Philip L McCarthy; Santiago Pavlovsky; J Douglas Rizzo; Thomas C Shea; Harry C Schouten; Shimon Slavin; Jane N Winter; Koen van Besien; Julie M Vose; Parameswaran N Hari
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):35-45.
2009: Thomas E Witzig; Peter H Wiernik; Timothy Moore; Craig Reeder; Craig Cole; Glen Justice; Henry Kaplan; Michael Voralia; Dennis Pietronigro; Kenichi Takeshita; Annette Ervin-Haynes; Jerome B Zeldis; Julie M Vose
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5404-9.
2009: Timothy S Fenske; Parameswaran Hari; Jeanette Carreras; Mei-Jie Zhang; Rammurti T Kamble; Brian J Bolwell; Mitchell S Cairo; Richard E Champlin; Yi-Bin Chen; Cesar O Freytes; Robert Peter Gale; gregory alan hale; Osman Ilhan; H Jean Khoury; John Lister; Dipnarine Maharaj; David I Marks; Reinhold Munker; Andrew L Pecora; Philip Rowlings; Thomas C Shea; Patrick J Stiff; Peter H Wiernik; Jane N Winter; J Douglas Rizzo; Koen van Besien; Hillard M Lazarus; Julie M Vose
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1455-64.
2009: Kenneth C Anderson; Melissa Alsina; William Bensinger; J Sybil Biermann; Asher Chanan-Khan; Adam D Cohen; Steven Devine; Benjamin Djulbegovic; Cristina Gasparetto; Carol Ann Huff; Madan Jagasia; Bruno C Medeiros; Ruby Meredith; Noopur Raje; Jeffrey Schriber; Seema Singhal; George Somlo; Keith E Stockerl-Goldstein; Guido Tricot; Julie M Vose; Donna Weber; Joachim Yahalom; Furhan Yunus
NCCN clinical practice guidelines in oncology: multiple myeloma.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(9):908-42.
2009: William W L Choi; Dennis D Weisenburger; Timothy C Greiner; Miguel A Piris; Alison H Banham; Jan Delabie; Rita M Braziel; Huimin Geng; Javeed Iqbal; Georg Lenz; Julie M Vose; Christine P Hans; Kai Fu; Lynette M Smith; Min Li; Zhongfeng Liu; Randy D Gascoyne; Andreas Rosenwald; German Ott; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; David L Jaye; Louis M Staudt; Wing C Chan
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5494-502.
2009: Julie M Vose; Anthony D Ho; Bertrand Coiffier; Paolo Corradini; Issa Khouri; Anna Sureda; Koen van Besien; John Dipersio
Advances in mobilization for the optimization of autologous stem cell transplantation.
Leukemia & lymphoma 2009;50(9):1412-21.
2009: Koen van Besien; Jeanette Carreras; Philip J Bierman; Brent R Logan; Arturo Molina; Roberta King; Gene Nelson; Joseph W Fay; Richard E Champlin; Hillard M Lazarus; Julie M Vose; Parameswaran N Hari
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):554-63.
2009: Thomas M Habermann; Izidore S Lossos; Glen Justice; Julie M Vose; Peter H Wiernik; Kyle McBride; Kenton Wride; Annette Ervin-Haynes; Kenichi Takeshita; Dennis Pietronigro; Jerome B Zeldis; Joseph M Tuscano
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
British journal of haematology 2009;145(3):344-9.
2009: Jonathan W Friedberg; Michael D Taylor; James Cerhan; Christopher R Flowers; Hildy Dillon; Charles Michael Farber; Eric S Rogers; John D Hainsworth; Elaine K Wong; Julie M Vose; Andrew D Zelenetz; Brian K Link
Follicular lymphoma in the United States: first report of the national LymphoCare study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1202-8.
2009: Marcel P Devetten; Parameswaran N Hari; Jeanette Carreras; Brent R Logan; Koen van Besien; Christopher N Bredeson; Cesar O Freytes; Robert Peter Gale; John Gibson; Sergio Giralt; Steven C Goldstein; Vikas Gupta; David I Marks; Richard T Maziarz; Julie M Vose; Hillard M Lazarus; Paolo Anderlini
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):109-17.
2008: Hillard M Lazarus; Jeanette Carreras; Christian Boudreau; Fausto R Loberiza; James O Armitage; Brian J Bolwell; Cesar O Freytes; Robert Peter Gale; John Gibson; gregory alan hale; David J Inwards; Charles F LeMaistre; Dipnarine Maharaj; David I Marks; Alan Marshall Miller; Santiago Pavlovsky; Harry C Schouten; Koen van Besien; Julie M Vose; Jacob D Bitran; Issa F Khouri; Philip L McCarthy; Hongmei Yu; Philip Rowlings; Derek S Serna; Mary M Horowitz; J Douglas Rizzo
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1323-33.
2008: Ibrahim T Aldoss; Dennis D Weisenburger; Kai Fu; Wing C Chan; Julie M Vose; Philip J Bierman; R Gregory Bociek; James O Armitage
Adult Burkitt lymphoma: advances in diagnosis and treatment.
Oncology (Williston Park, N.Y.) 2008;22(13):1508-17.
2008: Peter H Wiernik; Izidore S Lossos; Joseph M Tuscano; Glen Justice; Julie M Vose; Craig E Cole; Wendy Lam; Kyle McBride; Kenton Wride; Dennis Pietronigro; Kenichi Takeshita; Annette Ervin-Haynes; Jerome B Zeldis; Thomas M Habermann
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4952-7.
2008: Ken H Young; Karen Leroy; Michael B Møller; Gisele W B Colleoni; Margarita Sánchez-Beato; Fábio R Kerbauy; Corinne Haioun; Jens Eickhoff; Allen H Young; Philippe Gaulard; Miguel A Piris; Terry D Oberley; William M Rehrauer; Brad S Kahl; James S Malter; Elias Campo; Jan Delabie; Randy D Gascoyne; Andreas Rosenwald; Lisa M Rimsza; James Huang; Rita M Braziel; Elaine S Jaffe; Wyndham H Wilson; Louis M Staudt; Julie M Vose; Wing C Chan; Dennis D Weisenburger; Timothy C Greiner
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
Blood 2008;112(8):3088-98.
2008: Julie M Vose
Peripheral T-cell non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 2008;22(5):997-1005, x.
2008: Kai Fu; Dennis D Weisenburger; William W L Choi; Kyle D Perry; Lynette M Smith; Xinlan Shi; Christine P Hans; Timothy C Greiner; Philip J Bierman; R Gregory Bociek; James O Armitage; Wing C Chan; Julie M Vose
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4587-94.
2008: Sonali M Smith; Koen van Besien; Jeanette Carreras; Asad Bashey; Mitchell S Cairo; Cesar O Freytes; Robert Peter Gale; gregory alan hale; Brandon Hayes-Lattin; Leona A Holmberg; Armand Keating; Richard T Maziarz; Philip L McCarthy; Willis H Navarro; Santiago Pavlovsky; Harry C Schouten; Matthew Seftel; Peter H Wiernik; Julie M Vose; Hillard M Lazarus; Parameswaran Hari
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):904-12.
2008: Kerry J Savage; Nancy Lee Harris; Julie M Vose; Fred Ullrich; Elaine S Jaffe; Joseph Michael Connors; Lisa M Rimsza; Stefano A Pileri; Mukesh Chhanabhai; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Blood 2008;111(12):5496-504.
2008: John P Leonard; Stephanie A Gregory; David G Maloney; Julie M Vose; Anas Younes; Andrew D Zelenetz
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Clinical advances in hematology & oncology : H&O 2008;6(6):437-45.
2008: Ganapati V Hegde; Corey M Munger; Katy Emanuel; Avadhut Joshi; Timothy C Greiner; Dennis D Weisenburger; Julie M Vose; Shantaram S Joshi
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma.
Molecular cancer therapeutics 2008;7(6):1450-60.
2008: Peter McLaughlin; Julie M Vose
R-DHAP: a good small step, but not the journey's end.
Leukemia & lymphoma 2008;49(6):1019-21.
2008: Andrew D Zelenetz; Ranjana H Advani; John C Byrd; Myron S Czuczman; Lloyd E Damon; Madeleine Duvic; Luis Fayad; Andres Forero; Martha J Glenn; Jon P Gockerman; Leo I Gordon; Nancy Lee Harris; Richard T Hoppe; Steven Horwitz; Mark S Kaminski; Youn H Kim; Ann S LaCasce; Auyporn Nademanee; Elise A Olsen; Pierluigi Porcu; Oliver Press; Leonard R Prosnitz; Mitchell R Smith; Eduardo M Sotomayor; Julie M Vose; Joachim Yahalom; Furhan Yunus
Non-Hodgkin's lymphomas.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(4):356-421.
2008: Parameswaran Hari; Jeanette Carreras; Mei-Jie Zhang; Robert Peter Gale; Brian J Bolwell; Christopher N Bredeson; Linda J Burns; Mitchell S Cairo; Cesar O Freytes; Steven C Goldstein; gregory alan hale; David J Inwards; Charles F LeMaistre; Dipnarine Maharaj; David I Marks; Harry C Schouten; Shimon Slavin; Julie M Vose; Hillard M Lazarus; Koen van Besien
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):236-45.
2008: Julie M Vose; Philip J Bierman; Fausto R Loberiza; James C Lynch; Gregory Bociek; Dennis D Weisenburger; James O Armitage
Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):36-42.
2007: Apar Kishor Ganti; Stephanie J Lee; Julie M Vose; Marcel P Devetten; R Gregory Bociek; James O Armitage; Philip J Bierman; Lori J Maness; Elizabeth C Reed; Fausto R Loberiza
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(35):5643-8.
2007: Julie M Vose
Current status of rituximab maintenance therapy.
Clinical advances in hematology & oncology : H&O 2007;5(12):968-9,1006.
2007: Keshav Rao; Deborah L Darrington; Joseph J Schumacher; Marcel P Devetten; Julie M Vose; Fausto R Loberiza
Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1508-14.
2007: Javeed Iqbal; Timothy C Greiner; K Patel; Bhavana J Dave; L Smith; J Ji; George Wright; Warren G Sanger; Diane L Pickering; S Jain; Douglas E Horsman; Y Shen; Kai Fu; Dennis D Weisenburger; Christine P Hans; Elias Campo; Randy D Gascoyne; Andreas Rosenwald; Elaine S Jaffe; Jan Delabie; Lisa M Rimsza; German Ott; Hans Konrad Müller-Hermelink; Joseph Michael Connors; Julie M Vose; Timothy W McKeithan; Louis M Staudt; Wing C Chan
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.
Leukemia 2007;21(11):2332-43.
2007: Avadhut Joshi; Ganapati V Hegde; John D Dickinson; Amit K Mittal; James C Lynch; James D Eudy; James O Armitage; Philip J Bierman; R Gregory Bociek; Marcel P Devetten; Julie M Vose; Shantaram S Joshi
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5295-304.
2007: Rakesh K Singh; Michelle L Varney; Cheryl Leutzinger; Julie M Vose; Philip J Bierman; Suleyman Buyukberber; Kazuhiko Ino; Kevin Loh; Craig Nichols; David Inwards; Robert Rifkin; James Edward Talmadge
Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell products.
International immunopharmacology 2007;7(8):1033-43.
2007: Adrian Wiestner; Mahsa Tehrani; Michael Chiorazzi; George Wright; Federica Gibellini; Kazutaka Nakayama; Hui Liu; Andreas Rosenwald; H Konrad Muller-Hermelink; German Ott; Wing C Chan; Timothy C Greiner; Dennis D Weisenburger; Julie M Vose; James O Armitage; Randy D Gascoyne; Joseph Michael Connors; Elias Campo; Emili Montserrat; Francesc Bosch; Erlend Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Richard I Fisher; Thomas M Grogan; Thomas P Miller; Wyndham H Wilson; Elaine S Jaffe; Louis M Staudt
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
Blood 2007;109(11):4599-606.
2007: Michael J Robertson; Brad S Kahl; Julie M Vose; Sven de Vos; Mary Laughlin; Patrick J Flynn; Kendrith M Rowland; Jose C Cruz; Stuart L Goldberg; Luna Musib; Christelle Darstein; Nathan Enas; Jeffery L Kutok; Jon C Aster; Donna Neuberg; Kerry J Savage; Ann S LaCasce; Donald Thornton; Christopher A Slapak; Margaret A Shipp
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1741-6.
2007: Julie M Vose; Philip J Bierman; Fausto R Loberiza; R Gregory Bociek; Daniel Matso; James O Armitage
Phase I trial of (90)Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation.
Leukemia & lymphoma 2007;48(4):683-90.
2007: Apar Kishor Ganti; Julie M Vose; William D Haire
Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis.
Journal of thrombosis and thrombolysis 2007;23(2):155-8.
2007: Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph Michael Connors; Massimo Federico; Volker Diehl
Revised response criteria for malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):579-86.
2007: Kenneth C Anderson; Melissa Alsina; William Bensinger; J Sybil Biermann; Asher Chanan-Khan; Raymond Comenzo; Carlos M De Castro; Benjamin Djulbegovic; Sherif Farag; Carol Ann Huff; Ruby Meredith; Jeffrey Schriber; Dennis C Shrieve; Seema Singhal; Mitchell R Smith; Keith Stockerl-Goldstein; Julie M Vose; Donna Weber; Joachim Yahalom; Furhan Yunus
Multiple myeloma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(2):118-47.
2007: Maher Albitar; Julie M Vose; Marcella M Johnson; Kim-Anh Do; Amanda Day; Iman Jilani; Andrew Lamb; Michael Keating; Susan M O'Brien; Srdan Verstovsek; James O Armitage; Francis Giles
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Leukemia research 2007;31(2):139-45.
2007: Avadhut Joshi; John D Dickinson; Ganapati V Hegde; Warren G Sanger; James O Armitage; Philip J Bierman; R Gregory Bociek; Marcel P Devetten; Julie M Vose; Shantaram S Joshi
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
Cancer genetics and cytogenetics 2007;172(2):120-6.
2007: Julie M Vose; Amit Panwalkar; Robert Belanger; Bertrand Coiffier; Michele Baccarani; Stephanie A Gregory; Thierry Facon; Renato Fanin; Dolores Caballero; Dina Ben-Yehuda; Francis Giles
A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma.
Leukemia & lymphoma 2007;48(1):39-45.
2006: Charles L Bennett; Andrew M Evens; Leslie A Andritsos; Lakshmi Balasubramanian; Mark Mai; Matthew J Fisher; Timothy M Kuzel; Cara Angelotta; June M McKoy; Julie M Vose; Philip J Bierman; David J Kuter; Steven M Trifilio; Steven M Devine; Martin S Tallman
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
British journal of haematology 2006;135(5):642-50.
2006: Abdel-Kader Ashour; Jason L Petersen; Mary M McIlhaney; Julie M Vose; Joyce C Solheim
Effect of linkage of transduction domain sequences to a lymphoma idiotype DNA vaccine on vaccine effectiveness.
Hybridoma (2005) 2006;25(5):306-8.
2006: Mary Lee H Villanueva; Julie M Vose
The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Clinical advances in hematology & oncology : H&O 2006;4(7):521-30.
2006: Corey M Munger; Julie M Vose; Shantaram S Joshi
Dendritic cell-based therapy for mantle cell lymphoma.
International journal of oncology 2006;28(6):1337-43.
2006: Apar Kishor Ganti; Dennis D Weisenburger; Lynette M Smith; Christine P Hans; R Gregory Bociek; Philip J Bierman; Julie M Vose; James O Armitage
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):920-7.
2006: Julie M Vose
Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach.
Hematological oncology 2006;24(2):47-55.
2006: Willis Navarro; Fausto R Loberiza; Ruta Bajorunaite; Koen van Besien; Julie M Vose; Hillard M Lazarus; J Douglas Rizzo
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):541-51.
2006: Richard I Fisher; Bertrand Coiffier; Julie M Vose
Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas.
Clinical advances in hematology & oncology : H&O 2006;4(4):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10.
2006: James O Armitage; Philip J Bierman; R Gregory Bociek; Julie M Vose
Lymphoma 2006: classification and treatment.
Oncology (Williston Park, N.Y.) 2006;20(3):231-9; discussion 242, 244, 249.
2006: Andrew D Zelenetz; Ranjana Advani; Francis Buadi; Fernando Cabanillas; Michael A Caligiuri; Myron S Czuczman; Lloyd E Damon; Luis Fayad; Ian W Flinn; Andres Forero; Martha J Glenn; Jon P Gockerman; Leo I Gordon; Nancy Lee Harris; Richard T Hoppe; Mark S Kaminski; Ann S LaCasce; Auyporn Nademanee; Pierluigi Porcu; Oliver W Press; Leonard R Prosnitz; Mitchell R Smith; Eduardo M Sotomayor; Julie M Vose; Joachim Yahalom
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(3):258-310.
2006: Javeed Iqbal; Vishala T Neppalli; George Wright; Bhavana J Dave; Douglas E Horsman; Andreas Rosenwald; James Lynch; Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Elias Campo; German Ott; Hans Konrad Müller-Hermelink; Jan Delabie; Elaine S Jaffe; Thomas M Grogan; Joseph Michael Connors; Julie M Vose; James O Armitage; Louis M Staudt; Wing C Chan
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):961-8.
2006: Timothy C Greiner; Chiranjib Dasgupta; Vincent V Ho; Dennis D Weisenburger; Lynette M Smith; James C Lynch; Julie M Vose; Kai Fu; James O Armitage; Rita M Braziel; Elias Campo; Jan Delabie; Randy D Gascoyne; Elaine S Jaffe; H Konrad Muller-Hermelink; German Ott; Andreas Rosenwald; Louis M Staudt; Michael Y Im; Mazen W Karaman; Brian L Pike; Wing C Chan; Joseph G Hacia
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(7):2352-7.
2005: Julie M Vose
Personalized immunotherapy for the treatment of non-Hodgkin lymphoma: a promising approach.
Clinical advances in hematology & oncology : H&O 2005;3(12):923-32.
2005: Julie M Vose; B K Link; M L Grossbard; Myron S Czuczman; A Grillo-Lopez; Richard I Fisher
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Leukemia & lymphoma 2005;46(11):1569-73.
2005: Richard I Fisher; Mark S Kaminski; Richard L Wahl; Susan J Knox; Andrew D Zelenetz; Julie M Vose; John P Leonard; Stewart Kroll; Stanley J Goldsmith; Morton Coleman
Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7565-73.
2005: Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Wing C Chan; Patricia Aoun; Gregory T Cochran; Zenggang Pan; Lynette M Smith; James C Lynch; R Gregory Bociek; Philip J Bierman; Julie M Vose; James O Armitage
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1377-84.
2005: Malik E Juweid; Gregory A Wiseman; Julie M Vose; Justine M Ritchie; Yusuf Menda; James E Wooldridge; Felix Mottaghy; Eric M Rohren; Norbert M Blumstein; Alan H Stolpen; Brian K Link; Sven N Reske; Michael M Graham; Bruce D Cheson
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4652-61.
2005: Lodovico Balducci; Harvey Jay Cohen; Paul F Engstrom; David S Ettinger; Jeffrey Halter; Leo I Gordon; Krystyna Kiel; Andrew Kneier; Dean Lim; Stephen H Petersdorf; Ronnie Rosenthal; Rebecca Silliman; Julie M Vose; Michael J Walker; Babu Zachariah
Senior adult oncology clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):572-90.
2005: Myron S Czuczman; Aron Thall; Thomas E Witzig; Julie M Vose; Anas Younes; Christos Emmanouilides; Thomas P Miller; Joseph O Moore; John P Leonard; Leo I Gordon; John Sweetenham; Baha Alkuzweny; Deborah M Finucane; Bryan R Leigh
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(19):4390-8.
2005: John M Bennett; Mark S Kaminski; John P Leonard; Julie M Vose; Andrew D Zelenetz; Susan J Knox; Sandra Horning; Oliver W Press; John A Radford; Stewart M Kroll; Robert L Capizzi
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
Blood 2005;105(12):4576-82.
2005: Steven Z Pavletic; Lynette M Smith; Michael Bishop; James C Lynch; stefano r tarantolo; Julie M Vose; Philip J Bierman; Abdul Hadi; James O Armitage; Anne Kessinger
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
American journal of hematology 2005;78(4):265-74.
2005: Apar Kishor Ganti; Philip J Bierman; James C Lynch; R Gregory Bociek; Julie M Vose; James O Armitage
Hematopoietic stem cell transplantation in mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):618-24.
2005: Apar Kishor Ganti; R Gregory Bociek; Philip J Bierman; Charles A Enke; Julie M Vose; James O Armitage
Follicular lymphoma: expanding therapeutic options.
Oncology (Williston Park, N.Y.) 2005;19(2):213-28; discussion 228, 233-6, 239.
2005: Julie M Vose; Philip J Bierman; Charles A Enke; Jordan Hankins; Gregory Bociek; James C Lynch; James O Armitage
Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):461-7.
2005: Julie M Vose; M Neumann; Mildred E Harris
Update on lymphoma management: diffuse large B-cell NHL.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():10-4.
2004: Marcel P Devetten; Julie M Vose
Graft-versus-host disease: how to translate new insights into new therapeutic strategies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):815-25.
2004: Cesar O Freytes; Fausto R Loberiza; J Douglas Rizzo; Asad Bashey; Christopher N Bredeson; Mitchell S Cairo; Robert Peter Gale; Mary M Horowitz; Thomas R Klumpp; Rodrigo Martino; Philip L McCarthy; Arturo Molina; Santiago Pavlovsky; Andrew L Pecora; Derek S Serna; Tsuong Tsai; Mei-Jie Zhang; Julie M Vose; Hillard M Lazarus; Koen van Besien
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.
Blood 2004;104(12):3797-803.
2004: Marin Nola; Steven Z Pavletic; Dennis D Weisenburger; Lynette M Smith; Martin Bast; Julie M Vose; James O Armitage
Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma.
American journal of hematology 2004;77(1):31-5.
2004: James Z Huang; Dennis D Weisenburger; Julie M Vose; Timothy C Greiner; Patricia Aoun; Wing C Chan; James C Lynch; Philip J Bierman; James O Armitage
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group.
Leukemia & lymphoma 2004;45(8):1551-7.
2004: Javeed Iqbal; Warren G Sanger; Douglas E Horsman; Andreas Rosenwald; Diane L Pickering; Bhavana J Dave; Sandeep Dave; Li Xiao; Kajia Cao; Quiming Zhu; Simon Sherman; Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; German Ott; Hans Konrad Müller-Hermelink; Jan Delabie; Rita M Braziel; Elaine S Jaffe; Elias Campo; James C Lynch; Joseph Michael Connors; Julie M Vose; James O Armitage; Thomas M Grogan; Louis M Staudt; Wing C Chan
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
The American journal of pathology 2004;165(1):159-66.
2004: Andres Forero; Paul L Weiden; Julie M Vose; Susan J Knox; Albert F LoBuglio; Jordan Hankins; Michael L Goris; Vincent J Picozzi; Axworthy Don; Hazel Breitz; Robert B Sims; Richard G Ghalie; Sui Shen; Ruby F Meredith
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Blood 2004;104(1):227-36.
2004: Francis Giles; Julie M Vose; Kim-Anh Do; Marcella M Johnson; Taghi Manshouri; Gregory Bociek; Philip J Bierman; Susan M O'Brien; Hagop M Kantarjian; James O Armitage; Maher Albitar
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma.
Leukemia research 2004;28(6):595-604.
2004: Julie M Vose; Douglas J Rizzo; Jing Tao-Wu; James O Armitage; Asad Bashey; Linda J Burns; Neal Christiansen; Cesar O Freytes; Robert Peter Gale; John Gibson; Sergio Giralt; Roger H Herzig; Charles F LeMaistre; Philip L McCarthy; Stephen D Nimer; Finn B Petersen; David P Schenkein; Peter H Wiernik; Joseph M Wiley; Fausto R Loberiza; Hillard M Lazarus; Koen van Biesen; Mary M Horowitz
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):116-27.
2004: Julie M Vose
Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma.
The oncologist 2004;9(2):160-72.
2003: Francis Giles; Julie M Vose; Kim-Anh Do; Marcella M Johnson; Taghi Manshouri; Gregory Bociek; Philip J Bierman; Susan M O'Brien; Michael J Keating; Hagop M Kantarjian; James O Armitage; Maher Albitar
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.
British journal of haematology 2003;123(5):850-7.
2003: Koen van Besien; Fausto R Loberiza; Ruta Bajorunaite; James O Armitage; Asad Bashey; Linda J Burns; Cesar O Freytes; John Gibson; Mary M Horowitz; David J Inwards; David I Marks; Rodrigo Martino; Richard T Maziarz; Arturo Molina; Santiago Pavlovsky; Andrew L Pecora; Harry C Schouten; Thomas C Shea; Hillard M Lazarus; J Douglas Rizzo; Julie M Vose
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.
Blood 2003;102(10):3521-9.
2003: James Z Huang; Dennis D Weisenburger; Julie M Vose; Timothy C Greiner; Patricia Aoun; Wing C Chan; James C Lynch; Philip J Bierman; James O Armitage
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
Leukemia & lymphoma 2003;44(11):1903-10.
2003: Philip J Bierman; John W Sweetenham; Fausto R Loberiza; Goli Taghipour; Hillard M Lazarus; J Douglas Rizzo; Norbert Schmitz; Koen van Besien; Julie M Vose; Mary Horowitz; Anthony Goldstone
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(20):3744-53.
2003: Malik E Juweid; Gerald L DeNardo; Michael Graham; Julie M Vose
Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(5):673-4.
2003: Theresa Hahn; Steven Neil Wolff; Myron S Czuczman; Richard I Fisher; Hillard M Lazarus; Philip L McCarthy; Julie M Vose; Lisa Warren; Richard Watt
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(10):667.
2003: Steven Z Pavletic; R Gregory Bociek; James M Foran; Ronald J Rubocki; Charles A Kuszynski; James L Wisecarver; Lori Hatcher; David M Lucas; John C Byrd; Michael R Grever; Shantaram S Joshi; Penny Hardiman; Lynette M Smith; Timothy R McGuire; Philip J Bierman; Julie M Vose; James O Armitage; James Edward Talmadge
Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.
Transplantation 2003;76(5):877-81.
2003: Nicole Y Fang; Timothy C Greiner; Dennis D Weisenburger; Wing C Chan; Julie M Vose; Lynette M Smith; James O Armitage; R Aeryn Mayer; Brian L Pike; Francis S Collins; Joseph G Hacia
Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(9):5372-7.
2003: Maribeth A Hohenstein; Samuel C Augustine; Frank J Rutar; Julie M Vose
Establishing an institutional model for the administration of tositumomab and iodine I 131 tositumomab.
Seminars in oncology 2003;30(2 Suppl 4):39-49.
2003: John E Levine; Richard E Harris; Fausto R Loberiza; James O Armitage; Julie M Vose; Koen van Besien; Hillard M Lazarus; Mary M Horowitz; Asad Bashey; Brian J Bolwell; Linda J Burns; Mitchell S Cairo; Richard E Champlin; Cesar O Freytes; John Gibson; Steve C Goldstein; Mary J Laughlin; John Lister; David I Marks; Richard T Maziarz; Alan Marshall Miller; Gustavo A Milone; Santiago Pavlovsky; Andrew L Pecora; J Douglas Rizzo; Gary Schiller; Harry C Schouten; Mei-Jie Zhang
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.
Blood 2003;101(7):2476-82.
2003: Christine P Hans; Dennis D Weisenburger; Julie M Vose; Lynette M Hock; James C Lynch; Patricia Aoun; Timothy C Greiner; Wing C Chan; R Gregory Bociek; Philip J Bierman; James O Armitage
A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
Blood 2003;101(6):2363-7.
2003: Elisabeth Vandenberghe; Carmen Ruiz de Elvira; Fausto R Loberiza; E Conde; A López-Guillermo; C Gisselbrecht; françois guilhot; Julie M Vose; Koen van Biesen; J Douglas Rizzo; Dennis D Weisenburger; Peter Isaacson; Mary M Horowitz; Anthony H Goldstone; Hillard M Lazarus; Norbert Schmitz
Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries.
British journal of haematology 2003;120(5):793-800.
2003: Catherine Metayer; Rochelle E Curtis; Julie M Vose; Kathleen A Sobocinski; Mary M Horowitz; Smita Bhatia; Joseph W Fay; Cesar O Freytes; Steven C Goldstein; Roger H Herzig; Armand Keating; Carole B Miller; Thomas J Nevill; Andrew L Pecora; J Douglas Rizzo; Stephanie F Williams; Chin-Yang Li; Lois B Travis; Daniel J Weisdorf
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.
Blood 2003;101(5):2015-23.
2003: Julie M Vose; M Crump; Hillard M Lazarus; Christos Emmanouilides; David P Schenkein; J Moore; S Frankel; Ian W Flinn; W Lovelace; James Hackett; BC Liang
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):514-9.
2003: Shantaram S Joshi; Michael Bishop; James C Lynch; stefano r tarantolo; Sunil Abhyankar; Philip J Bierman; Julie M Vose; RB Geller; Joseph P McGuirk; James M Foran; R Gregory Bociek; A Hadi; S D Day; James O Armitage; Anne Kessinger; Z Steven Pavletic
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Cytotherapy 2003;5(6):542-52.
2003: Julie M Vose; Vesna Sneller
Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14 Suppl 1():i17-20.
2002: Philip J Bierman; James C Lynch; R Gregory Bociek; V L Whalen; Anne Kessinger; Julie M Vose; James O Armitage
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1370-7.
2002: Julie M Vose; Graham Sharp; Wing C Chan; Craig Nichols; Kevin Loh; David Inwards; Robert Rifkin; Philip J Bierman; James C Lynch; Dennis D Weisenburger; Anne Kessinger; James O Armitage
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2344-52.
2002: Julie M Vose; Dennis D Weisenburger; James C Lynch; Philip J Bierman; John C Chan; Martin Bast; Patricia Aoun; Gregory Bociek; Timothy Greiner; James O Armitage
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
Leukemia & lymphoma 2002;43(4):799-804.
2002: Colin D Weekes; Julie M Vose; James C Lynch; Dennis D Weisenburger; Philip J Bierman; Timothy Greiner; Gregory Bociek; Charles A Enke; Martin Bast; Wing C Chan; James O Armitage
Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):1087-93.
2002: Julie M Vose; Brian Chiu; Bruce D Cheson; Janet Dancey; John Wright
Update on epidemiology and therapeutics for non-Hodgkin's lymphoma.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():241-62.
2002: Samuel C Augustine; Jeffrey P Norenberg; David Colcher; Julie M Vose; Lisa S Gobar; Valorie J Dukat; Maribeth A Hohenstein; Frank J Rutar; David A Jacobson; Margaret A Tempero
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice.
Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 2002;42(1):93-100.
2001: Mark S Kaminski; Andrew D Zelenetz; Oliver W Press; M Saleh; J Leonard; L Fehrenbacher; T Andrew Lister; RJ Stagg; George Tidmarsh; Stewart Kroll; Richard L Wahl; Susan J Knox; Julie M Vose
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3918-28.
2001: J Graham Sharp; Michael Bishop; B Copple; Timothy C Greiner; Patrick L Iversen; John D Jackson; Shantaram S Joshi; Eric J Benner; SL Mann; A K Rao; Julie M Vose
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells.
Leukemia & lymphoma 2001;42(3):417-27.
2001: Frank J Rutar; Samuel C Augustine; David Colcher; Jeffry A Siegel; D A Jacobson; Margaret A Tempero; V J Dukat; Maribeth A Hohenstein; Lisa S Gobar; Julie M Vose
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):907-15.
2001: A Khorana; P Bunn; P McLaughlin; Julie M Vose; Carleton Stewart; Myron S Czuczman
A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.
Leukemia & lymphoma 2001;41(1-2):77-87.
2001: Hillard M Lazarus; Fausto R Loberiza; Mei-Jie Zhang; James O Armitage; Karen K Ballen; Asad Bashey; Brian J Bolwell; Linda J Burns; Cesar O Freytes; Robert Peter Gale; J Gibson; Roger H Herzig; Charles F LeMaistre; D Marks; J Mason; Alan Marshall Miller; Gustavo A Milone; Santiago Pavlovsky; Donna Reece; J Douglas Rizzo; Koen van Besien; Julie M Vose; Mary M Horowitz
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Bone marrow transplantation 2001;27(4):387-96.
2001: Julie M Vose
Immunotherapy for non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2001;15(2):141-7, 151; discussion 152-5.
2001: Julie M Vose; Mei-Jie Zhang; Philip Rowlings; Hillard M Lazarus; Brian J Bolwell; Cesar O Freytes; Santiago Pavlovsky; Armand Keating; B Yanes; Koen van Besien; James O Armitage; Mary M Horowitz
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):406-13.
2001: Julie M Vose; B K Link; M L Grossbard; Myron S Czuczman; A Grillo-Lopez; P Gilman; A Lowe; L A Kunkel; Richard I Fisher
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):389-97.
2001: Julie M Vose; Philip J Bierman; James C Lynch; K Atkinson; C Juttner; C E Hanania; Gregory Bociek; James O Armitage
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(12):680-7.
2001: Theresa Hahn; Steven Neil Wolff; Myron S Czuczman; Richard I Fisher; Hillard M Lazarus; Julie M Vose; L Warren; R Watt; Philip L McCarthy
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(6):308-31.
2000: Michael Bishop; stefano r tarantolo; RB Geller; James C Lynch; Philip J Bierman; Z Steven Pavletic; Julie M Vose; S Kruse; SP Dix; M E Morris; James O Armitage; Anne Kessinger
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.
Blood 2000;96(1):80-5.
2000: Dennis D Weisenburger; Julie M Vose; Timothy C Greiner; James C Lynch; Wing C Chan; Philip J Bierman; Bhavana J Dave; Warren G Sanger; James O Armitage
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group.
American journal of hematology 2000;64(3):190-6.
2000: Julie M Vose; F Cabanillas; S O'Brien; N Dang; Ronny Drapkin; F Foss
Infectious complications of pentostatin therapy.
Oncology (Williston Park, N.Y.) 2000;14(6 Suppl 2):41-2.
2000: Julie M Vose; David Colcher; Lisa S Gobar; P J Bierman; Samuel C Augustine; Margaret A Tempero; PK Leichner; J C Lynch; D Goldenberg; J O Armitage
Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma.
Leukemia & lymphoma 2000;38(1-2):91-101.
2000: Rakesh K Singh; Michelle L Varney; Kazuhiko Ino; Julie M Vose; Philip J Bierman; James Edward Talmadge
Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients.
Experimental hematology 2000;28(5):499-507.
2000: Z Steven Pavletic; Edward R Arrowsmith; Philip J Bierman; Stacey A Goodman; Julie M Vose; stefano r tarantolo; Richard S Stein; Gregory Bociek; John P Greer; C D Wu; JP Kollath; Dennis D Weisenburger; Anne Kessinger; Steven Neil Wolff; James O Armitage; Michael Bishop
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
Bone marrow transplantation 2000;25(7):717-22.
2000: Julie M Vose; Richard L Wahl; M Saleh; Ama Z S Rohatiner; Susan J Knox; John A Radford; Andrew D Zelenetz; George Tidmarsh; RJ Stagg; Mark S Kaminski
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1316-23.
2000: Dennis D Weisenburger; Randy D Gascoyne; Philip J Bierman; T Shenkier; Douglas E Horsman; James C Lynch; Wing C Chan; Timothy C Greiner; Joseph Michael Connors; Julie M Vose; James O Armitage; Warren G Sanger
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma.
Leukemia & lymphoma 2000;36(5-6):513-23.
2000: Julie M Vose
Therapeutic uses of MAbs directed against CD20.
Cytotherapy 2000;2(6):455-61.
2000: Julie M Vose; Philip J Bierman; Dennis D Weisenburger; James C Lynch; Y Bociek; Wing C Chan; Timothy C Greiner; James O Armitage
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(6):640-5.
2000: Richard A Nash; R Kurzrock; John DiPersio; Julie M Vose; Charles Linker; D Maharaj; Auayporn Nademanee; R Negrin; Stephen D Nimer; Howard M Shulman; Mark Ashby; Denny Jones; Frederick R Appelbaum; Richard Champlin
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):25-34.
1999: Julie M Vose
Antibody-targeted therapy for low-grade lymphoma.
Seminars in hematology 1999;36(4 Suppl 6):15-20.
1999: M Freeman; Julie M Vose; Charles L Bennett; J Anderson; Anne Kessinger; K Turner; J Pierson; Michael Bishop; Philip J Bierman; J Armitage
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995.
Bone marrow transplantation 1999;24(6):679-84.
1999: H Tezcan; Julie M Vose; Martin Bast; Philip J Bierman; Anne Kessinger; James O Armitage
Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Leukemia & lymphoma 1999;34(3-4):273-85.
1999: Randy D Gascoyne; Patricia Aoun; D Wu; Mukesh Chhanabhai; Brian F Skinnider; Timothy C Greiner; S W Morris; Joseph Michael Connors; Julie M Vose; David S Viswanatha; Andrew J Coldman; Dennis D Weisenburger
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.
Blood 1999;93(11):3913-21.
1999: Bruce D Cheson; Sandra J Horning; Bertrand Coiffier; Margaret A Shipp; Richard I Fisher; J M Connors; T A Lister; Julie M Vose; Antonio J Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; James O Armitage; W Carter; R Hoppe; George P Canellos
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1244.
1999: K Scott Baker; Bruce G Gordon; Thomas G Gross; MA Abromowitch; Elizabeth Lyden; James C Lynch; Julie M Vose; James O Armitage; Peter F Coccia; Philip J Bierman
Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):825-31.
1999: Ashraf A Abou-Elella; Dennis D Weisenburger; Julie M Vose; JP Kollath; James C Lynch; Martin Bast; Philip J Bierman; Timothy C Greiner; Wing C Chan; James O Armitage
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):784-90.
1999: Hillard M Lazarus; Philip Rowlings; Mei-Jie Zhang; Julie M Vose; James O Armitage; P J Bierman; James L Gajewski; Robert Peter Gale; Armand Keating; John P Klein; Carole B Miller; Gordon L Phillips; Donna Reece; Kathleen A Sobocinski; Koen van Besien; Mary M Horowitz
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):534-45.
1999: AG Ageitos; Michelle L Varney; Philip J Bierman; Julie M Vose; Phyllis I Warkentin; James Edward Talmadge
Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products.
Bone marrow transplantation 1999;23(1):63-9.
1998: Z Steven Pavletic; Philip J Bierman; Julie M Vose; Michael Bishop; C D Wu; J L Pierson; JP Kollath; Dennis D Weisenburger; Anne Kessinger; James O Armitage
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1023-6.
1998: Colin D Weekes; Samuel J Pirruccello; Julie M Vose; Charles A Kuszynski; J Graham Sharp
Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival.
Leukemia & lymphoma 1998;31(1-2):151-65.
1998: Koen van Besien; Kathleen A Sobocinski; Philip Rowlings; S C Murphy; James O Armitage; Michael Bishop; O K Chaekal; Robert Peter Gale; John P Klein; Hillard M Lazarus; Philip L McCarthy; John M M Raemaekers; J Reiffers; Gordon L Phillips; A V M B Schattenberg; Leo F Verdonck; Julie M Vose; Mary M Horowitz
Allogeneic bone marrow transplantation for low-grade lymphoma.
Blood 1998;92(5):1832-6.
1998: Julie M Vose
Current approaches to the management of non-Hodgkin's lymphoma.
Seminars in oncology 1998;25(4):483-91.
1998: Ralph Hauke; Timothy C Greiner; BN Smir; Julie M Vose; stefano r tarantolo; R M Bashir; Philip J Bierman
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases.
Bone marrow transplantation 1998;21(12):1271-4.
1998: Steven H Bernstein; Auayporn Nademanee; Julie M Vose; Guido Tricot; Joseph W Fay; R S Negrin; John DiPersio; Gabriela Rondon; Richard Champlin; M J Barnett; K Cornetta; Geoffrey P Herzig; WP Vaughan; G Geils; Armand Keating; H Messner; Steven Neil Wolff; K B Miller; Charles Linker; Mitchell S Cairo; Sue Hellmann; Mark Ashby; S Stryker; Richard A Nash
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.
Blood 1998;91(9):3509-17.
1998: Julie M Vose; Philip J Bierman; James C Lynch; Dennis D Weisenburger; Anne Kessinger; Wing C Chan; Timothy C Greiner; James O Armitage
Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):844-9.
1998: William D Haire; EI Ruby; L Clifton Stephens; Elizabeth Reed; stefano r tarantolo; Z Steven Pavletic; Philip J Bierman; Michael Bishop; Anne Kessinger; Julie M Vose; James O Armitage
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):142-50.
1998: Julie M Vose
High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 1():S1-3.
1998: Z Steven Pavletic; Shantaram S Joshi; Samuel J Pirruccello; stefano r tarantolo; JP Kollath; Elizabeth C Reed; Philip J Bierman; Julie M Vose; Phyllis I Warkentin; Thomas G Gross; K Nasrati; James O Armitage; Anne Kessinger; Michael Bishop
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies.
Bone marrow transplantation 1998;21(1):33-41.
1997: G Q Wu; J Graham Sharp; G Wu; Julie M Vose; Timothy C Greiner; Wing C Chan
The detection of minimal lymphoma by molecular and combined culture-molecular methods.
British journal of haematology 1997;99(4):873-81.
1997: Julie M Vose; A N Pandite; R A Beveridge; RB Geller; M W Schuster; J E Anderson; Charles F LeMaistre; T Ahmed; A Granena; A Keating; J M Fernandez Ranada; Patrick J Stiff; I Tabbara; W Longo; Edward A Copelan; Craig Nichols; A Smith; D L Topolsky; Philip J Bierman; M E Lebsack; M Lange; L Garrison
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1617-23.
1997: Z Steven Pavletic; Michael Bishop; stefano r tarantolo; S Martin-Algarra; Philip J Bierman; Julie M Vose; Elizabeth C Reed; Thomas G Gross; JP Kollath; K Nasrati; John D Jackson; James O Armitage; Anne Kessinger
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1608-16.
1997: Michael Bishop; stefano r tarantolo; John D Jackson; James Robert Anderson; K Schmit-Pokorny; D Zacharias; Z Steven Pavletic; Samuel J Pirruccello; Julie M Vose; Philip J Bierman; Phyllis I Warkentin; James O Armitage; Anne Kessinger
Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1601-7.
1997: Philip J Bierman; Julie M Vose; James Robert Anderson; Michael Bishop; Anne Kessinger; James O Armitage
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):445-50.
1997: James Edward Talmadge; Elizabeth Reed; Kazuhiko Ino; Anne Kessinger; Charles A Kuszynski; Dean Heimann; Michelle L Varney; J Jackson; Julie M Vose; Philip J Bierman
Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Bone marrow transplantation 1997;19(2):161-72.
1996: Michael Bishop; John D Jackson; B O'Kane-Murphy; K Schmit-Pokorny; Julie M Vose; Philip J Bierman; Phyllis I Warkentin; James O Armitage; L Garrison; Anne Kessinger
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2521-6.
1996: Julie M Vose; Philip J Bierman; James Robert Anderson; K A Harrison; G V Dalrymple; Katherine L. Byar; Anne Kessinger; James O Armitage
Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2473-9.
1996: Julie M Vose; Philip J Bierman; E Ruby; Elizabeth C Reed; Michael Bishop; stefano r tarantolo; Anne Kessinger; James O Armitage
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Bone marrow transplantation 1996;17(6):951-6.
1996: Julie M Vose
Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma.
Seminars in oncology 1996;23(3 Suppl 6):33-7.
1996: Dennis D Weisenburger; Bruce G Gordon; Julie M Vose; M A Bast; Wing C Chan; Timothy C Greiner; James Robert Anderson; Warren G Sanger
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma.
Blood 1996;87(9):3860-8.
1996: B Jain; A A Floreani; James Robert Anderson; Julie M Vose; RA Robbins; Stephen I Rennard; Joseph H Sisson
Cardiopulmonary function and autologous bone marrow transplantation: results and predictive value for respiratory failure and mortality. The University of Nebraska Medical Center Bone Marrow Transplantation Pulmonary Study Group.
Bone marrow transplantation 1996;17(4):561-8.
1996: Philip J Bierman; Julie M Vose; Alan N Langnas; R M Rifkin; Ralph Hauke; BN Smir; Timothy C Greiner
Hodgkin's disease following solid organ transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):265-70.
1996: Philip J Bierman; James Robert Anderson; M B Freeman; Julie M Vose; Anne Kessinger; Michael Bishop; James O Armitage
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):151-6.
1996: James L Gajewski; Gordon L Phillips; Kathleen A Sobocinski; James O Armitage; Robert Peter Gale; Richard E Champlin; R H Herzig; D D Hurd; Sundar Jagannath; John P Klein; Hillard M Lazarus; Philip L McCarthy; S Pavlovsky; F B Peterson; Philip Rowlings; J A Russell; Samuel Michael Silver; Julie M Vose; P H Wiernik; M M Bortin; Mary M Horowitz
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):572-8.
1996: Julie M Vose; J E Anderson; Philip J Bierman; F R Appelbaum; James Robert Anderson; L Garrison; M E Lebsack; James O Armitage
Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):520-6.
1996: Julie M Vose
Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 6():S13-9.
1995: S Martin-Algarra; Michael Bishop; stefano r tarantolo; M K Cowles; E Reed; James Robert Anderson; Julie M Vose; Philip J Bierman; James O Armitage; Anne Kessinger
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Experimental hematology 1995;23(14):1503-8.
1995: William D Haire; E I Ruby; Bruce G Gordon; K D Patil; L Clifton Stephens; G D Kotulak; Elizabeth C Reed; Julie M Vose; Philip J Bierman; Anne Kessinger
Multiple organ dysfunction syndrome in bone marrow transplantation.
JAMA : the journal of the American Medical Association 1995;274(16):1289-95.
1995: Anne Kessinger; Michael Bishop; John D Jackson; B O'Kane-Murphy; Julie M Vose; Philip J Bierman; Elizabeth C Reed; Phyllis I Warkentin; James O Armitage; J Graham Sharp
Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.
Experimental hematology 1995;23(7):609-12.
1995: A R Martin; Dennis D Weisenburger; Wing C Chan; E I Ruby; James Robert Anderson; Julie M Vose; Philip J Bierman; M A Bast; D T Daley; James O Armitage
Prognostic value of cellular proliferation and histologic grade in follicular lymphoma.
Blood 1995;85(12):3671-8.
1995: Y Yan; Wing C Chan; Dennis D Weisenburger; James Robert Anderson; M A Bast; Julie M Vose; Philip J Bierman; James O Armitage
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1336-42.
1995: W P Vaughan; E Kris; Julie M Vose; Philip J Bierman; Peter R Gwilt; James O Armitage
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1089-95.
1995: Anne Kessinger; Michael Bishop; James Robert Anderson; James O Armitage; Philip J Bierman; Elizabeth C Reed; stefano r tarantolo; M A Tempero; Julie M Vose; Phyllis I Warkentin
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.
Journal of hematotherapy 1995;4(2):81-4.
1995: Julie M Vose
Chemotherapeutic palliative approaches in the treatment of lymphoma.
Seminars in oncology 1995;22(2 Suppl 3):53-7.
1995: Julie M Vose; James O Armitage
Clinical applications of hematopoietic growth factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):1023-35.
1995: D A Stewart; Julie M Vose; Dennis D Weisenburger; James Robert Anderson; E I Ruby; M A Bast; Philip J Bierman; Anne Kessinger; James O Armitage
The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(3):263-6.
1995: Julie M Vose
Cytokine use in the older patient.
Seminars in oncology 1995;22(1 Suppl 1):6-8.
1995: James O Armitage; Philip J Bierman; Julie M Vose; Michael Bishop; M A Kessinger
Autologous bone marrow transplantation for Hodgkin's disease.
Journal of hematotherapy 1995;4(1):61-2.
1995: Julie M Vose
CHLVPP therapy for Hodgkin's disease identification of prognostic factors.
Leukemia & lymphoma 1995;15 Suppl 1():13-4.
1994: D L Darrington; Julie M Vose; James Robert Anderson; Philip J Bierman; Michael Bishop; Wing C Chan; M E Morris; Elizabeth C Reed; Warren G Sanger; stefano r tarantolo
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2527-34.
1994: James O Armitage; Julie M Vose; Philip J Bierman; Michael Bishop
Salvage therapy for patients with lymphoma.
Seminars in oncology 1994;21(4 Suppl 7):82-5.
1994: Julie M Vose; James Robert Anderson; Philip J Bierman; M Bast; Dennis D Weisenburger; Wing C Chan; Michael Bishop; James O Armitage
Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
Seminars in hematology 1994;31(2 Suppl 3):4-8.
1994: Michael Bishop; James Robert Anderson; John D Jackson; Philip J Bierman; Elizabeth C Reed; Julie M Vose; James O Armitage; Phyllis I Warkentin; Anne Kessinger
High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.
Blood 1994;83(2):610-6.
1994: Anne Kessinger; J Armitage; Philip J Bierman; Michael Bishop; S Joshi; E Reed; G Sharp; J Talmadge; Julie M Vose
Clinical outcome of peripheral blood stem cell support.
Medical oncology (Northwood, London, England) 1994;11(2):43-6.
1994: Wing C Chan; G Q Wu; T C Greiner; Julie M Vose; J Graham Sharp
Detection of tumor contamination of peripheral stem cells in patients with lymphoma using cell culture and polymerase chain reaction technology.
Journal of hematotherapy 1994;3(3):175-84.
1993: Philip J Bierman; R G Bagin; Sundar Jagannath; Julie M Vose; G Spitzer; Anne Kessinger; K A Dicke; James O Armitage
High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):767-73.
1993: Julie M Vose; James Robert Anderson; Anne Kessinger; Philip J Bierman; P Coccia; Elizabeth C Reed; B Gordon; James O Armitage
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):1846-51.
1993: Julie M Vose; James O Armitage; Anne Kessinger
High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.
Oncology (Williston Park, N.Y.) 1993;7(8):23-9; discussion 29-30, 33-4.
1993: Julie M Vose; Elizabeth C Reed; G C Pippert; James Robert Anderson; Philip J Bierman; Anne Kessinger; J Spinolo; James O Armitage
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1306-10.
1993: Julie M Vose; James O Armitage
Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1993;7(3):577-90.
1993: H Nakamine; R G Bagin; Julie M Vose; M A Bast; Philip J Bierman; James O Armitage; Dennis D Weisenburger
Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma.
Cancer 1993;71(10):3130-7.
1993: Philip J Bierman; Julie M Vose; PK Leichner; Syed M Quadri; James O Armitage; J L Klein; R A Abrams; K A Dicke; huib vriesendorp
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):698-703.
1993: Peter C Iwen; Elizabeth C Reed; James O Armitage; P J Bierman; Anne Kessinger; Julie M Vose; M A Arneson; B A Winfield; G L Woods
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(3):131-9.
1993: James Robert Anderson; Julie M Vose; Philip J Bierman; D D Weisenberger; Warren G Sanger; J Pierson; M Bast; James O Armitage
Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):218-24.
1993: Julie M Vose; James O Armitage
What is the role of third generation regimens for initial therapy of non-Hodgkin's lymphomas?
Leukemia & lymphoma 1993;10 Suppl():61-4.
1993: Bruce G Gordon; Dennis D Weisenburger; Phyllis I Warkentin; J Anderson; Warren G Sanger; M Bast; D Gnarra; Julie M Vose; Philip J Bierman; James O Armitage
Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.
Cancer 1993;71(1):257-63.
1993: Michael Bishop; Philip J Bierman; Julie M Vose; James O Armitage
The role of high-dose therapy with hematopoietic stem cell rescue in low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4 Suppl 1():1-6.
1993: Anne Kessinger; Julie M Vose; Philip J Bierman; M Bishop; James O Armitage
Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.
Journal of hematotherapy 1993;2(3):361-2.
1992: Bruce G Gordon; Phyllis I Warkentin; Dennis D Weisenburger; Julie M Vose; Warren G Sanger; S E Strandjord; James Robert Anderson; J D Verdirame; Philip J Bierman; James O Armitage
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.
Blood 1992;80(11):2938-42.
1992: Julie M Vose; Philip J Bierman; James Robert Anderson; Anne Kessinger; J Pierson; J Nelson; B Frappier; K Schmit-Pokorny; Dennis D Weisenburger; James O Armitage
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.
Blood 1992;80(8):2142-8.
1992: S W Braddock; D Harrington; Julie M Vose
Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin.
Journal of the American Academy of Dermatology 1992;27(2 Pt 2):337-40.
1992: Joseph H Sisson; A B Thompson; James Robert Anderson; RA Robbins; John R Spurzem; P R Spence; Elizabeth C Reed; James O Armitage; Julie M Vose; M A Arneson
Airway inflammation predicts diffuse alveolar hemorrhage during bone marrow transplantation in patients with Hodgkin disease.
The American review of respiratory disease 1992;146(2):439-43.
1992: Julie M Vose; B C Kennedy; Philip J Bierman; Anne Kessinger; James O Armitage
Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies.
Cancer 1992;69(3):784-9.
1992: A S Masih; Dennis D Weisenburger; Julie M Vose; M A Bast; James O Armitage
Histologic grade does not predict prognosis in optimally treated, advanced-stage nodular sclerosing Hodgkin's disease.
Cancer 1992;69(1):228-32.
1992: B Letheby; J Jackson; J Greally; Phyllis I Warkentin; Douglas Smith; Julie M Vose; Philip J Bierman; Anne Kessinger; P Coccia; J Armitage
Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.
Progress in clinical and biological research 1992;377():345-51.
1991: James O Armitage; Philip J Bierman; Julie M Vose; James Robert Anderson; Dennis D Weisenburger; Anne Kessinger; Elizabeth C Reed; W P Vaughan; Peter F. Coccia; D T Purtilo
Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.
The American journal of medicine 1991;91(6):605-11.
1991: R M Bashir; Philip J Bierman; Julie M Vose; Dennis D Weisenburger; James O Armitage
Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma.
American journal of clinical oncology 1991;14(6):478-82.
1991: Anne Kessinger; Julie M Vose; Philip J Bierman; James O Armitage
High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
Experimental hematology 1991;19(10):1013-6.
1991: Julie M Vose; Philip J Bierman; Dennis D Weisenburger; James O Armitage
The therapy of non-Hodgkin's lymphomas. Introduction and overview.
Hematology/oncology clinics of North America 1991;5(5):845-52.
1991: Julie M Vose; Philip J Bierman; James Robert Anderson; Dennis D Weisenburger; D F Moravec; S Sorensen; M Hutchins; M D Dowling; D Howe; J Okerbloom
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1421-5.
1991: Anne Kessinger; Philip J Bierman; Julie M Vose; James O Armitage
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.
Blood 1991;77(11):2322-5.
1991: Julie M Vose; James O Armitage
The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():171-6.
1991: Julie M Vose; James O Armitage
Diffuse "histiocytic" lymphoma.
Seminars in oncology 1991;18(1):50-60.
1991: Julie M Vose; Philip J Bierman; Anne Kessinger; Peter F Coccia; J Anderson; F B Oldham; C Epstein; James O Armitage
The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Bone marrow transplantation 1991;7(2):139-43.
1990: Julie M Vose; Philip J Bierman; James O Armitage
Hodgkin's disease: the role of bone marrow transplantation.
Seminars in oncology 1990;17(6):749-57.
1990: Harry C Schouten; D Maragos; Julie M Vose; James O Armitage
Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation.
Bone marrow transplantation 1990;6(5):333-5.
1990: Julie M Vose; C Peterson; Philip J Bierman; Dennis D Weisenburger; J Linder; D Harrington; W P Vaughan; Anne Kessinger; James O Armitage
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.
Blood 1990;76(2):424-31.
1989: James O Armitage; Julie M Vose; J Linder; Dennis D Weisenburger; D Harrington; J Casey; Philip J Bierman; S Sorensen; M Hutchins; D F Moravec
Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(12):1783-90.
1989: Harry C Schouten; Philip J Bierman; W P Vaughan; Anne Kessinger; Julie M Vose; Dennis D Weisenburger; James O Armitage
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.
Blood 1989;74(7):2579-84.
1989: Julie M Vose; James O Armitage; Philip J Bierman; Dennis D Weisenburger; M Hutchins; M D Dowling; D F Moravec; S Sorensen; J Okerbloom; G Bascom
Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.
The American journal of medicine 1989;87(3):285-8.
1988: Julie M Vose; James O Armitage; Dennis D Weisenburger; Philip J Bierman; S Sorensen; M Hutchins; D F Moravec; D Howe; M D Dowling; J Mailliard
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(12):1838-44.
1988: Julie M Vose; James O Armitage; M Duggan; S W Braddock
Pyoderma gangrenosum or cutaneous lymphoma: a difficult clinical diagnosis.
Cutis; cutaneous medicine for the practitioner 1988;42(4):335-7.
1988: Julie M Vose; J Armitage; Dennis D Weisenburger; D Moravec; M Hutchins; D Howe; S Sorensen; M Dowling; J Okerbloom; W Pevnick
ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
American journal of clinical oncology 1988;11(4):423-6.